BrainCo Launches 'FocusEase Medical Edition' for ADHD Children Aged 6–12, Files IPO Prospectus

On January 31, BrainCo released the "Focus欣" Medical Edition Attention Training System. This product is specifically designed for children aged 6-12 with Attention Deficit Hyperactivity Disorder (ADHD). It consists of ADHD rehabilitation training software and a single-channel prefrontal EEG collector, providing a medical-grade solution for auxiliary ADHD rehabilitation training for children in this age group.

As a落地成果 of BrainCo's non-invasive brain-computer interface technology in the field of children's neurodevelopment, "Focus欣" has established a comprehensive and in-depth patent layout, owning over 70 related invention patents. The patents cover the complete technical closed loop of "signal acquisition-decoding analysis-application feedback," forming a full-chain core technology barrier from hardware design, signal processing to software content.

The core of the product relies on neurofeedback training technology, which is developed based on brain science and behavioral science learning theories. It utilizes the plasticity of brain neurons and helps children achieve autonomous regulation and improvement of target brain neural activities through scientific training mechanisms such as rewards and reinforcement. This process facilitates the repair and enhancement of brain functions at the neural level, achieving professional auxiliary rehabilitation effects that range from alleviating surface symptoms to optimizing deep-level brain functions. (Pengpai News reporter Zhou Ling)